Verrica Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VRCA and other ETFs, options, and stocks.About VRCA
Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315.
CEOJayson M. Rieger
CEOJayson M. Rieger
Employees71
Employees71
HeadquartersWest Chester, Pennsylvania
HeadquartersWest Chester, Pennsylvania
Founded2013
Founded2013
Employees71
Employees71
VRCA Key Statistics
Market cap79.81M
Market cap79.81M
Price-Earnings ratio-2.45
Price-Earnings ratio-2.45
Dividend yield—
Dividend yield—
Average volume638.52K
Average volume638.52K
High today$8.48
High today$8.48
Low today$7.20
Low today$7.20
Open price$7.38
Open price$7.38
Volume195.26K
Volume195.26K
52 Week high$12.00
52 Week high$12.00
52 Week low$3.28
52 Week low$3.28
Stock Snapshot
Verrica Pharmaceuticals(VRCA) stock is priced at $8.35, giving the company a market capitalization of 79.81M. It carries a P/E multiple of -2.45.
On 2025-12-04, Verrica Pharmaceuticals(VRCA) stock moved within a range of $7.20 to $8.48. With shares now at $8.35, the stock is trading +16.0% above its intraday low and -1.5% below the session's peak.
Trading activity shows a volume of 195.26K, compared to an average daily volume of 638.52K.
The stock's 52-week range extends from a low of $3.28 to a high of $12.00.
The stock's 52-week range extends from a low of $3.28 to a high of $12.00.
People also own
Based on the portfolios of people who own VRCA. This list is generated using Robinhood data, and it’s not a recommendation.